1. Accueil Zonebourse
  2. Actions
  3. Royaume-Uni
  4. London Stock Exchange
  5. GSK plc
  6. Actualités
  7. Autres langues
    GSK   GB00BN7SWP63


Temps Différé London Stock Exchange  -  17:35 09/08/2022
1646.80 GBX   -0.76%
08/08GlaxoSmithKline et IQVIA lancent un outil de suivi des données de vaccination
08/08GSK plc et IQVIA lancent Vaccine Track
08/08GSK PLC : UBS maintient son opinion neutre
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur GSK PLC
08/08Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Com..
08/08GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker
08/08GSK plc and IQVIA launch Vaccine Track
08/08ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help imp..
08/08El FTSE 100 sube por las ganancias de los valores petroleros, industriales y financiero..
08/08GSK : Ubs cuts target price to 1820p from 1860p…
08/08Climate change puts Lyme disease in focus for France's Valneva after COVID blow
05/08UK Financial Watchdog Fines Ex-ConvaTec Chair For Sharing Inside Information
05/08GSK : Morgan stanley resumes coverage with equal weight; target p…
03/08European ADRs Nudge Higher in Wednesday Trading
03/08GLAXOSMITHKLINE : GSK Announces Offer to Repurchase Exchangeable Senior Notes Due 2023 - F..
03/08GSK Offers to Buy Back $280 Million of 2023 Notes
03/08GSK Announces Offer To Repurchase Exchangeable Senior Notes Due 2023
03/08Gsk - its wholly owned unit, gsk finance plc, is offering to rep…
03/08Gsk announces offer to repurchase exchangeable senior notes due…
02/08COVID : Ue sigla contratto con Hipra per 250 mln dosi vaccino
01/08GLAXOSMITHKLINE : Director/Pdmr Shareholding - Form 6-K
29/07GLAXOSMITHKLINE : GSK Board change - Form 6-K
29/07GLAXOSMITHKLINE : Q2 2022 results transcript (PDF - 477.6KB)
29/07GSK Says Laurie Glimcher Has Advised Co Of Her Intention To Retire
29/07Laurie Glimcher Advises GSK of Intention to Retire from the Board on 13 October 2022
29/07GSK Unit ViiV Healthcare's HIV Prevention Drug Shows Lower Rate Of New Infections Among..
29/07GSK's ViiV Healthcare Strikes Deal to Allow Generic Versions of HIV Prevention Drug in ..
28/07GlaxoSmithKline-backed ViiV Healthcare Enters Licensing Deal With Medicines Patent Pool..
28/07GLOBAL MARKETS LIVE : Best Buy, Diageo, Mastercard, Pfizer, Qualcomm...
28/07Cheap copies of GSK's HIV prevention drug could be ready in 2026
28/07Copias genéricas del medicamento de GSK para prevenir el VIH podrían estar listas en 20..
28/07Cheap copies of GSK's HIV prevention drug could be ready in 2026
28/07GLAXOSMITHKLINE : ViiV Healthcare announces new data at AIDS 2022 from unblinded phase of ..
28/07EU sichert Millionen Dosen Grippe-Impfstoff gegen mögliche Pandemie
28/07EU sichert sich bis zu 85 Millionen Dosen Grippe-Impfstoff
28/07GSK Signs Framework Contract With EU For Future Pandemic Vaccine
28/07GLAXOSMITHKLINE : GSK signs agreement to support pandemic preparedness in Europe
28/07Analysis-As inflation soars, European consumer goods M&A slows
27/07GlaxoSmithKline's Lupus Nephritis Drug Secures US FDA Approval for Treatment of Childre..
27/07GSK says U.S. FDA approves kidney disease drug for children
27/07GSK says U.S. FDA approves kidney disease drug for children
27/07GSK Gets US FDA Approval Of Benlysta For Pediatric Patients With Active Lupus Nephritis
27/07GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Activ..
27/07GSK plc Announces US Food and Drug Administration Approval of Benlysta for Pediatric Pa..
27/07GLOBAL MARKETS LIVE : Adidas, Alphabet, Chipotle, Spotify, Shopify...
27/07GSK Lupus Treatment Approved for Pediatric Patients by U.S. FDA
27/07FTSE 100 Closes Wednesday Up on Positive Earnings Reports
27/07GLAXOSMITHKLINE : Q2 2022 US dollar translation ( - 0b)
27/07¿Crisis del coste de la vida? Los consumidores europeos siguen gastando
27/07Cost of living crisis? Europe's consumers keep spending
27/07MIDDAY BRIEFING - Unternehmen und Märkte -2-
27/07Gsk plc Provides Dividend Guidance for Second Half 2022 and for full year 2023
27/07TRANSCRIPT : GSK plc, Q2 2022 Earnings Call, Jul 27, 2022
27/07GSK Posts Higher Q2 Adjusted Earnings, Sales
27/07Lloyds Banking's Scope for Shareholder Returns Improves, Says Barclays
27/07GSK hebt nach deutlichem Gewinnanstieg Prognose an
27/07GSK CEO : "world has started to recognize that adult vaccination…
27/07FTSE 100 Gains as Lloyds, Oil Majors Rise; Rio Tinto Disappoints
27/07GSK CEO : "the great growth that we have reported this year is v…
27/07GSK CEO : "our industry is less exposed than many other industri…
27/07GSK CEO : Co focused on the future of vaccines in an endemic cov…
27/07GSK CEO : Co has more appetite for m&a…
27/07GSK CEO : Co not currently in any discussions with any other co…
27/07GSK Banks on Vaccines, Specialty Medicines to Achieve Upgraded 2022 Targets Post-Haleon..
27/07CORRECTION : GSK's H1 Profit Rises On Strong Growth In Product Groups, Turnover
27/07Rio Tinto Dividend Miss Sours Earnings Beat
27/07FTSE 100 to Open Higher With Focus on Fed
27/07GSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 Outlook -- Update
27/07GLAXOSMITHKLINE : Q2 2022 results slides
27/07GLAXOSMITHKLINE : Q2 2022 clinical trials summary (PDF - 999.2KB)
27/07GLAXOSMITHKLINE : Q2 2022 results infographic (PDF - 87.4KB)
27/07GUTE IMPFSTOFFNACHFRAGE : GlaxoSmithKline hebt Jahresziele an
27/07Haleon Sees Up to 8% Organic Revenue Growth in FY22 After H1 Rise
27/07Haleon 2Q Organic Revenue Boosted by Portfolio Strength, Innovation
27/07GSK's H1 Profit Rises On Strong Growth In Product Groups, Commercial Operations Turnove..
27/07GSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 Outlook
27/07GLAXOSMITHKLINE : GSK delivers strong Q2 2022 sales of £6.9 billion +19% at AER, +13% at C..
27/07GSK lifts full-year forecast, days after consumer health spinoff
27/07GLAXOSMITHKLINE : Q2 2022 results announcement (PDF - 1.5MB)
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur GSK PLC